ACCELERANT HOLDINGS-CL A (ARX) Fundamental Analysis & Valuation

NYSE:ARX • KYG008941083

10.66 USD
-0.23 (-2.11%)
At close: Mar 11, 2026
10.66 USD
0 (0%)
After Hours: 3/11/2026, 4:15:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ARX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

ARX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 149 industry peers in the Insurance industry. The financial health of ARX is average, but there are quite some concerns on its profitability. ARX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. ARX Profitability Analysis

1.1 Basic Checks

  • In the past year ARX has reported negative net income.
  • In the past year ARX had a positive cash flow from operations.
ARX Yearly Net Income VS EBIT VS OCF VS FCFARX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • ARX has a worse Return On Assets (-17.86%) than 93.29% of its industry peers.
  • ARX's Return On Equity of -207.57% is on the low side compared to the rest of the industry. ARX is outperformed by 93.29% of its industry peers.
  • ARX has a worse Return On Invested Capital (0.71%) than 64.43% of its industry peers.
Industry RankSector Rank
ROA -17.86%
ROE -207.57%
ROIC 0.71%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARX Yearly ROA, ROE, ROICARX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -10 -20

1.3 Margins

  • With a Operating Margin value of 9.41%, ARX perfoms like the industry average, outperforming 43.62% of the companies in the same industry.
  • The Profit Margin and Gross Margin are not available for ARX so they could not be analyzed.
Industry RankSector Rank
OM 9.41%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARX Yearly Profit, Operating, Gross MarginsARX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10 -20 -30 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ARX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARX is destroying value.
  • Compared to 1 year ago, ARX has about the same amount of shares outstanding.
  • The debt/assets ratio for ARX has been reduced compared to a year ago.
ARX Yearly Shares OutstandingARX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
ARX Yearly Total Debt VS Total AssetsARX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.03, we must say that ARX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ARX (0.03) is better than 68.46% of its industry peers.
  • ARX has a debt to FCF ratio of 0.21. This is a very positive value and a sign of high solvency as it would only need 0.21 years to pay back of all of its debts.
  • ARX's Debt to FCF ratio of 0.21 is amongst the best of the industry. ARX outperforms 89.93% of its industry peers.
  • ARX has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ARX (0.18) is better than 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.21
Altman-Z 0.03
ROIC/WACC0.08
WACC8.66%
ARX Yearly LT Debt VS Equity VS FCFARX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • ARX has a Current Ratio of 0.17. This is a bad value and indicates that ARX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ARX has a Current ratio of 0.17. This is in the better half of the industry: ARX outperforms 67.11% of its industry peers.
  • A Quick Ratio of 0.17 indicates that ARX may have some problems paying its short term obligations.
  • With a decent Quick ratio value of 0.17, ARX is doing good in the industry, outperforming 67.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
ARX Yearly Current Assets VS Current LiabilitesARX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ARX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 155.73% over the past year.
  • ARX shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.63%.
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23389%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%

3.2 Future

  • ARX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.07% yearly.
  • The Revenue is expected to grow by 26.85% on average over the next years. This is a very strong growth
EPS Next Y545.47%
EPS Next 2Y129.79%
EPS Next 3Y89.58%
EPS Next 5Y65.07%
Revenue Next Year55.46%
Revenue Next 2Y32.59%
Revenue Next 3Y26.24%
Revenue Next 5Y26.85%

3.3 Evolution

ARX Yearly Revenue VS EstimatesARX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ARX Yearly EPS VS EstimatesARX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ARX Valuation Analysis

4.1 Price/Earnings Ratio

  • ARX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 16.33, the valuation of ARX can be described as correct.
  • Based on the Price/Forward Earnings ratio, ARX is valued a bit more expensive than the industry average as 68.46% of the companies are valued more cheaply.
  • ARX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.39.
Industry RankSector Rank
PE N/A
Fwd PE 16.33
ARX Price Earnings VS Forward Price EarningsARX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • ARX's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARX indicates a somewhat cheap valuation: ARX is cheaper than 71.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.04
EV/EBITDA 7.72
ARX Per share dataARX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ARX's earnings are expected to grow with 89.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y129.79%
EPS Next 3Y89.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARX Dividend Analysis

5.1 Amount

  • No dividends for ARX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARX Fundamentals: All Metrics, Ratios and Statistics

ACCELERANT HOLDINGS-CL A

NYSE:ARX (3/11/2026, 4:15:00 PM)

After market: 10.66 0 (0%)

10.66

-0.23 (-2.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-12
Earnings (Next)03-19
Inst Owners47.32%
Inst Owner Change0%
Ins Owners49.06%
Ins Owner Change-0.54%
Market Cap2.36B
Revenue(TTM)802.70M
Net Income(TTM)-1.40B
Analysts78.57
Price Target20.91 (96.15%)
Short Float %3.72%
Short Ratio1.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.16%
Min EPS beat(2)6.63%
Max EPS beat(2)75.69%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)3.07%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.64%
PT rev (3m)-0.81%
EPS NQ rev (1m)2.83%
EPS NQ rev (3m)2.9%
EPS NY rev (1m)0.64%
EPS NY rev (3m)9.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.33
P/S 2.95
P/FCF 4.04
P/OCF 3.78
P/B 3.5
P/tB 5.1
EV/EBITDA 7.72
EPS(TTM)-6.82
EYN/A
EPS(NY)0.65
Fwd EY6.12%
FCF(TTM)2.64
FCFY24.77%
OCF(TTM)2.82
OCFY26.43%
SpS3.62
BVpS3.05
TBVpS2.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.86%
ROE -207.57%
ROCE 0.99%
ROIC 0.71%
ROICexc 0.91%
ROICexgc 3.15%
OM 9.41%
PM (TTM) N/A
GM N/A
FCFM 72.97%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.21
Debt/EBITDA 1.09
Cap/Depr 108.59%
Cap/Sales 4.88%
Interest Coverage 7.26
Cash Conversion 559.95%
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z 0.03
F-Score5
WACC8.66%
ROIC/WACC0.08
Cap/Depr(3y)271.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23389%
EPS Next Y545.47%
EPS Next 2Y129.79%
EPS Next 3Y89.58%
EPS Next 5Y65.07%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%
Revenue Next Year55.46%
Revenue Next 2Y32.59%
Revenue Next 3Y26.24%
Revenue Next 5Y26.85%
EBIT growth 1Y245.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year681.3%
EBIT Next 3Y115.67%
EBIT Next 5Y72.97%
FCF growth 1Y191.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y170.93%
OCF growth 3YN/A
OCF growth 5YN/A

ACCELERANT HOLDINGS-CL A / ARX FAQ

What is the ChartMill fundamental rating of ACCELERANT HOLDINGS-CL A (ARX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ARX.


Can you provide the valuation status for ACCELERANT HOLDINGS-CL A?

ChartMill assigns a valuation rating of 4 / 10 to ACCELERANT HOLDINGS-CL A (ARX). This can be considered as Fairly Valued.


What is the profitability of ARX stock?

ACCELERANT HOLDINGS-CL A (ARX) has a profitability rating of 1 / 10.


What is the earnings growth outlook for ACCELERANT HOLDINGS-CL A?

The Earnings per Share (EPS) of ACCELERANT HOLDINGS-CL A (ARX) is expected to grow by 545.47% in the next year.